Some studies indicated that 67 dysregulated lncRNAs associated with the PI3K/AKT/mTOR pathway show oncogenic or anti-oncogenic effects in hepatocellular carcinoma by regulating epigenetic, transcriptional, and post-transcriptional levels [47]. This evidence concerns the gene MTOR and hepatocellular carcinoma.